Фармакоэкономическая оценка использования антигипертензивных препаратов пациентами декретированной и недекретированной групп населения

Е В Слободенюк, С. Ш. Сулейманов, Н. В. Абросимова et al. · Dalʹnevostočnyj medicinskij žurnal · 2005

Marketing researches analyzing the pharmaceutical market of the Khabarovsk territory showed similarities and differences in sales of hypertensive drugs at full price and their distribution free of charge. To treat patients with car-dio-vascular diseases who receive drugs free of charge is more expensive because the amount of sales of free medicines two times higher in comparison with medications bought at full price. Enalapril has a high percentage of sales irrespective of the form of payment (free or at full price). ABC-analysis based on the volume of sales showed that in case of sales at full price groups A” and ”B” contain such medications as raunatin, adelfan-ezidrex, trirezid K, papazol, an-dipal providing no profit for drug stories. Clophilin takes 23 position on the list of sales, other medications are either absent (papazol, andipal, raunatm, cnstepin) or belong to the group C adelfan-ezidrex.

Cited by 0 works.

Authors